China Health Group Inc (8225) - Financial and Strategic SWOT Analysis Review

  • ID: 4432313
  • SWOT Analysis
  • Region: China
  • 30 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Genscript Biotech Corp
  • Pharmaron Beijing Co Ltd
  • MORE
China Health Group Inc (8225) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

China Health Group Inc (CHG), formerly known as Venturepharm Laboratories Limited, is an investment holding company. The company’s offerings include regulatory services, clinical research, post-marketing clinical services and extension service for new product launch. Its therapeutic expertise spans across oncology, central nervous system, cardiovascular, respiratory, dermatology as well as HIVS and allergy areas. CHG’s clientele include pharmaceutical and biotechnology companies in Europe, North America, Asia, and Africa. It operates through subsidiaries in the UK, the US, and China. CHG is headquartered in Haidian District, Beijing, China.

China Health Group Inc Key Recent Developments

Dec 19, 2016: China Health Group: Resignation of Non-Executive Directors, Appointment Of Executive Director and Non- Executive Director
May 11, 2016: China Medical Group entered a new stage of development
Apr 18, 2016: China Health Group appoints new Financial Director

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Genscript Biotech Corp
  • Pharmaron Beijing Co Ltd
  • MORE
Section 1 - About the Company
  • China Health Group Inc - Key Facts
  • China Health Group Inc - Key Employees
  • China Health Group Inc - Key Employee Biographies
  • China Health Group Inc - Major Products and Services
  • China Health Group Inc - History
  • China Health Group Inc - Company Statement
  • China Health Group Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • China Health Group Inc - Business Description
  • China Health Group Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • China Health Group Inc - Strengths
  • China Health Group Inc - Weaknesses
  • China Health Group Inc - Opportunities
  • China Health Group Inc - Threats
  • China Health Group Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Recent Developments
  • Dec 19, 2016: China Health Group: Resignation of Non-Executive Directors, Appointment Of Executive Director and Non- Executive Director
  • May 11, 2016: China Medical Group entered a new stage of development
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • China Health Group Inc, Key Facts
  • China Health Group Inc, Key Employees
  • China Health Group Inc, Key Employee Biographies
  • China Health Group Inc, Major Products and Services
  • China Health Group Inc, History
  • China Health Group Inc, Subsidiaries
  • China Health Group Inc, Key Competitors
  • China Health Group Inc, Ratios based on current share price
  • China Health Group Inc, Annual Ratios
  • China Health Group Inc, Annual Ratios (Cont...1)
  • China Health Group Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • China Health Group Inc, Performance Chart (2012 - 2016)
  • China Health Group Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Wuxi Pharmatech (Cayman) Inc
  • Wincon TheraCells Biotechnologies Co Ltd
  • Pharmaron Beijing Co Ltd
  • Genscript Biotech Corp
  • Fountain Medical Development Corp
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll